Belite Bio, Inc. (BLTE)
177.46
-5.70
(-3.11%)
USD |
NASDAQ |
Sep 10, 12:51
Belite Bio Total Liabilities (Quarterly) : 14.95M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.95M |
| March 31, 2026 | 15.48M |
| December 31, 2025 | 10.07M |
| September 30, 2025 | 8.311M |
| June 30, 2025 | 6.522M |
| March 31, 2025 | 6.131M |
| December 31, 2024 | 6.311M |
| Date | Value |
|---|---|
| September 30, 2024 | 3.621M |
| June 30, 2024 | 3.837M |
| March 31, 2024 | 4.677M |
| December 31, 2023 | 4.211M |
| September 30, 2023 | 4.804M |
| June 30, 2023 | 4.978M |
| March 31, 2023 | 4.649M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.29M |
| CorMedix, Inc. | 443.22M |
| Eloxx Pharmaceuticals, Inc. | 16.97M |
| Cannabis Global, Inc. | 6.178M |
| Breakthrough Chemistry, Inc. | 0.4631M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 791.58M |
| Shareholders Equity (Quarterly) | 776.64M |